| Literature DB >> 26740270 |
Timothy Ross Elliott1, Tiffany Symes2, George Kannourakis3, Peter Angus4.
Abstract
Liver injury due to idiosyncratic drug reactions can be difficult to diagnose and may lead to acute liver failure (ALF), which has a high mortality rate. N-acetylcysteine (NAC) is effective treatment for paracetamol toxicity, but its role in non-paracetamol drug-induced ALF is controversial. We report on the use of a validated bedside tool to establish causality for drug-induced liver injury (DILI) and describe the first case of resolution of norfloxacin-induced ALF after NAC therapy. NAC is easy to administer and generally has a good safety profile. We discuss the evidence to support the use of NAC in ALF secondary to DILI and possibilities for further clinical research in this field. 2016 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26740270 PMCID: PMC4716361 DOI: 10.1136/bcr-2015-213189
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X